...
首页> 外文期刊>Surgical Endoscopy >Patient factors predictive of 24-h pH normalization following endoluminal gastroplication for GERD.
【24h】

Patient factors predictive of 24-h pH normalization following endoluminal gastroplication for GERD.

机译:患者因素可预测GERD腔内胃复胃后24小时pH值正常化。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Endoluminal full-thickness gastroplication has been documented to provide significant and long-lasting improvement of GERD symptoms and health-related quality of life (HRQL) with very little patient morbidity. These treatments, however, are criticized for normalizing esophageal acid exposure in only 30-40% of patients treated. We hypothesize that there are objective criteria that will identify those patients who will have a normal DeMeester score (DMS) following endoluminal treatment. METHODS: Data from a prospective multicenter trial using the NDO Plicator device to treat GERD were available for statistical analysis. All patients were treated with endoluminal full-thickness gastroplication. All patients had GERD symptoms and abnormal 24-h pH exposure preoperatively. Postoperative objective outcome was assessed by performing 24-h pH studies at 6 months. Univariate and multivariate regression analyses were performed to determine factors predictive of successful treatment (normalized 24-h pH). RESULTS: A total of 266 patients were included in the study. Mean preoperative DMS was 47.91 (+/-31.34). Postoperatively, mean DMS decreased significantly (37.11 +/- 24.63, p < 0.001), and 31.67% of patients had a DMS within normal range (DMS < 22). Results of multivariate regression analysis demonstrated that the following preoperative patient characteristics were predictive of postoperative success (normal DMS): DMS < 30 (odds ratio [OR] = 4.24, 95% confidence interval [CI] = 1.73, 10.36, p < 0.001), heartburn score < 2 (OR = 3.37, CI = 1.44, 7.89, p = 0.005), and BMI < 30 (OR = 4.93, CI = 1.55, 15.61, p = 0.007). CONCLUSION: Data analysis from this prospective study indicates that the odds of objective success would be significantly greater if the treatment was restricted to thinner patients with mild reflux disease. This may help define the optimal place for endoluminal therapy in a comprehensive GERD treatment algorithm.
机译:背景:腔内全厚度胃气化术已被证明可以显着且持久地改善GERD症状和健康相关的生活质量(HRQL),而患者的发病率却很少。然而,这些疗法因仅使30-40%的患者使食管酸暴露正常化而受到批评。我们假设存在客观标准,这些标准可以识别出腔内治疗后DeMeester评分(DMS)正常的患者。方法:使用NDO Plicator装置治疗GERD的前瞻性多中心试验数据可用于统计分析。所有患者均接受腔内全厚度胃溃疡治疗。所有患者术前均有GERD症状和24小时pH暴露异常。通过在6个月内进行24小时pH研究评估术后客观结果。进行单因素和多因素回归分析,以确定可预测成功治疗的因素(标准化的24小时pH)。结果:总共266例患者被纳入研究。术前平均DMS为47.91(+/- 31.34)。术后,平均DMS显着下降(37.11 +/- 24.63,p <0.001),并且31.67%的DMS在正常范围内(DMS <22)。多元回归分析结果表明,以下术前患者特征可预测术后成功(正常DMS):DMS <30(优势比[OR] = 4.24,95%置信区间[CI] = 1.73,10.36,p <0.001) ,胃灼热评分<2(OR = 3.37,CI = 1.44,7.89,p = 0.005),BMI <30(OR = 4.93,CI = 1.55,15.61,p = 0.007)。结论:该前瞻性研究的数据分析表明,如果治疗仅限于较轻的轻度反流病患者,客观上成功的几率会更大。这可能有助于在综合GERD治疗算法中确定腔内治疗的最佳位置。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号